Option Care director granted stock awards

KRAEMER HARRY M JANSEN JR reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/22/2026 - 06:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

KRAEMER HARRY M JANSEN JR reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health director Harry M. Jansen Kraemer Jr. reported two stock-based compensation awards on common stock. He received 12,079 restricted stock units valued using a $200,000 target amount based on the May 20, 2026 closing price, plus 8,997 restricted stock units granted in lieu of cash retainer fees. Both awards vest in full on May 20, 2027 and represent equity compensation grants, not open-market purchases.

Insider Trade Summary

Grant/Award: 21,076 shares

Grant/Award 2 txns

Insider KRAEMER HARRY M JANSEN JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,997	$0.00	$0.00
Grant/Award	Common Stock	12,079	$22.23	$269K

Holdings After Transaction: Common Stock — 471,076 shares (Direct)

Footnotes (2)

1. F1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
2. F2. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Key Figures

RSU award value: $200,000 RSUs granted (value-based award): 12,079 shares RSUs in lieu of cash retainer: 8,997 shares +4 more

7 metrics

RSU award value $200,000 Target value for 12,079 restricted stock units on May 20, 2026

RSUs granted (value-based award) 12,079 shares Restricted stock units granted May 20, 2026 based on closing price

RSUs in lieu of cash retainer 8,997 shares Restricted stock units received instead of cash fees on May 20, 2026

Grant price reference $22.23 per share Transaction price per share shown for 12,079-share award

Holdings after one grant 471,076 shares Total common shares following the 12,079-share award

Holdings after other grant 458,997 shares Total common shares following the 8,997-share award

Vesting date May 20, 2027 Both restricted stock unit awards vest in full on this date

Key Terms

restricted stock units, cash retainer payments, closing price, Form 4

4 terms

restricted stock units financial

"The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

cash retainer payments financial

"The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027."

closing price financial

"The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OPCH director Harry M. Jansen Kraemer Jr. report in this Form 4?

He reported receiving two equity compensation awards of common stock. One award reflects 12,079 restricted stock units, and a second reflects 8,997 restricted stock units granted instead of cash fees, all vesting in 2027.

How large is the main stock award reported by OPCH director Kraemer?

The main award equals 12,079 restricted stock units, calculated to reflect $200,000 of value. The grant size was based on the issuer’s common stock closing price on May 20, 2026, according to the disclosure footnote.

Were the OPCH stock awards open-market purchases or compensation grants?

They were compensation grants, not open-market purchases. The Form 4 uses transaction code "A" and describes them as awards of restricted stock units, including units received instead of cash director retainer payments.

When do Harry Kraemer’s new OPCH restricted stock units vest?

Both sets of restricted stock units vest in full on May 20, 2027. Until vesting, the awards represent unvested equity compensation that is scheduled to become fully vested on that future date if standard conditions are met.

How were the OPCH restricted stock units in lieu of cash calculated?

These restricted stock units were granted instead of cash retainer payments, with the number of units calculated from the cash fees amount. The filing states the calculation used the issuer’s May 20, 2026 common stock closing price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRAEMER HARRY M JANSEN JR

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		8,997(1)	A	$0	458,997	D
Common Stock	05/20/2026		A		12,079(2)	A	$22.23	471,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

2. The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Kraemer	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)